{"schema_version":"secwatch.filing_event.v1","accession":"0000926617-23-000016","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2023-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.621185+00:00","generated_at":"2026-06-18T13:59:19.725266+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Aspira Women's Health appoints Dr. Jordan as Chair; Palmieri resigns as Executive Chair and director","bullets":["Dr. Veronica G.H. Jordan appointed Chair of the Board, effective March 1, 2023.","Dr. Robert Auerbach stepped down as Lead Independent Director, effective March 1, 2023.","Valerie Palmieri's term as Executive Chair concluded March 1, 2023; she resigned from the Board.","Palmieri's departure follows the terms of her Amended and Restated Employment Agreement dated March 1, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0000926617-23-000016","json":"https://secwatch.observer/filing/0000926617-23-000016.json","markdown":"https://secwatch.observer/filing/0000926617-23-000016.md","text":"https://secwatch.observer/filing/0000926617-23-000016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000092661723000016/0000926617-23-000016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000092661723000016/awh-20230228x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T13:59:19.725266+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5c06dcb085","claim":"Valerie Palmieri resigned as Executive Chair at Aspira Women's Health Inc..","evidence_excerpt":"Ms. Palmieri’s term as Executive Chair of the Company concluded on March 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000092661723000016/0000926617-23-000016-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Executive Chair"}],"fact_type":"executive_change"},{"claim_id":"6b18c22ac7","claim":"Dr. Robert Auerbach changed role as Lead Independent Director at Aspira Women's Health Inc..","evidence_excerpt":"Dr. Robert Auerbach stepped down as the Company’s Lead Independent Director, effective as of March 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000092661723000016/0000926617-23-000016-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Lead Independent Director"}],"fact_type":"executive_change"},{"claim_id":"f38030556f","claim":"Dr. Veronica G.H. Jordan was appointed as Chair of the Board at Aspira Women's Health Inc..","evidence_excerpt":"the board of directors (the “Board”) of Aspira Women’s Health Inc. (the “Company”) appointed Dr. Veronica G.H. Jordan as the Chair of the Board , effective as of March 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000092661723000016/0000926617-23-000016-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chair of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}